The American Society of Gene & Cell Therapy informs the media and public about new developments in gene and cell therapy and gene and cell therapy research through position statements. Following are links to recent ASGCT position statements.

• ASGT Position Statement on Informed Consent (August 2008)
  
  
• NIH Funding of Gene Therapy Trials (September 29, 2006)
  
  
• Strategic Plan Work Group and Recap of Recommendations(September 24, 2004)
  
  
• Report from the ASGT Ad Hoc Committee on Retroviral-mediated Gene Transfer to Hematopoietic Stem Cells
  
  
• ASGT Response to FDA Critical Path Statement (July 2004)
  
  
• Report from the ASGT Ad Hoc Committee on Retroviral-mediated Gene Transfer to Hematopoietic Stem Cells (April, 2003)
  
  
• Policy of The American Society of Gene Therapy on Financial Conflict of Interest in Clinical Research (Adopted April 15, 2000)
  
  

• Reporting of Patient Adverse Events in Gene Therapy Trials: Statement from the American Society of Gene Therapy
  (Adopted December 14, 1999)